These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8111834)
41. [Cytostatics in general practice]. Høst H Tidsskr Nor Laegeforen; 1980 Feb; 100(5):267. PubMed ID: 7385147 [No Abstract] [Full Text] [Related]
42. [Clinical pharmacology of immunosuppressive cytostatics]. Hvidberg E Nord Med; 1970 Nov; 84(47):1496-7. PubMed ID: 5486020 [No Abstract] [Full Text] [Related]
43. [The possible mutagenic effect of cytostatics on nurses at an oncologic department]. Larsen H; Madsen ES Ugeskr Laeger; 1984 Oct; 146(41):3135-7. PubMed ID: 6515952 [No Abstract] [Full Text] [Related]
44. [Cytostatics as a residue risk]. Horneman T Sykepleien; 1980 Sep; 67(16):36-7. PubMed ID: 6905351 [No Abstract] [Full Text] [Related]
50. Basis for seeking new types and structures for chemotherapeutic agents. SKIPPER HE; BAKER BR; JONES R Natl Cancer Inst Monogr; 1960 Aug; 3():59-69. PubMed ID: 13831485 [No Abstract] [Full Text] [Related]
51. [Present status in the development of new antineoplastic agents]. Klener P Cas Lek Cesk; 1994 Jan; 133(1):6-9. PubMed ID: 8111834 [TBL] [Abstract][Full Text] [Related]
52. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
53. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
54. [Disorders of the cardiovascular system during treatment of oncologic diseases]. Elbl L Vnitr Lek; 2002 Jul; 48(7):619-25. PubMed ID: 12197403 [TBL] [Abstract][Full Text] [Related]
55. [Perspectives of medical therapy of solid tumours]. Koza I Vnitr Lek; 2001 Aug; 47(8):510-5. PubMed ID: 15633386 [TBL] [Abstract][Full Text] [Related]